SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-13-442115
Filing Date
2013-11-14
Accepted
2013-11-14 16:13:11
Documents
6
Period of Report
2013-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d629293d8ka.htm 8-K/A 15221
2 EX-99.1 d629293dex991.htm EX-99.1 86716
3 EX-99.2 d629293dex992.htm EX-99.2 109193
4 GRAPHIC g62929314_1.jpg GRAPHIC 44848
5 GRAPHIC g629293g21v86.jpg GRAPHIC 4749
6 GRAPHIC g629293snap2.jpg GRAPHIC 7115
  Complete submission text file 0001193125-13-442115.txt   290859
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19825 | Film No.: 131220007
SIC: 2834 Pharmaceutical Preparations